Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
alcohol
alcohol, neurologic complications with
alcoholic withdrawal states, DT's, convulsions, etc.
algorithm
alpha-fetoprotein
altered states of consciousness, driving with
amniocentesis
anoxia
anticoagulant, complications of
anticoagulant, discontinuation
anticoagulant, reversal of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
anticonvulsants, absorption
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, brand name
anticonvulsants, compliance
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, effectiveness
anticonvulsants, generic
anticonvulsants, selection of
anticonvulsants, subtherapeutic
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
antihypertensive
antiviral agents
arrhythmia, cardiac
artificial intelligence
aspirin
atrial fibrillation
atrial tachycardia
automobile accidents
brand name drug
breast feeding
carbamazepine
carbamazepine, controlled release
cardiac arrest
central nervous system, infection of
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, silent
cerebrovascular disease
children
compliance
complications
computers, medicine and
conflict of interest
congenital birth defects
congenital malformation
controversies in neurology
cop 1
cost
coumarin
counselling
dabigatran
diet
differential diagnosis
dilantin
dilantin, free
dilantin, serum level
dilantin, suspension
Driver's license
driving
driving restrictions
driving restrictions, compliance
driving test
drug induced neurologic disorders
drug interactions
drug overdose
educational status
efficacy
emergency room
employment
enzyme, induction
epilepsy referral centers
fatigue
fetus
fever
flu-like illness
folic acid
fosphenytoin
fracture, long bone
generic drugs
genetic counselling
head injury
headache
heparin, subcutaneous
highly active antiretroviral therapy
hospitalization
human immunodeficiency virus type 1
human immunodeficiency virus type 1, prophylaxis
hypertension
hyperthermia
hypocalcemia
hypoglycemia
hyponatremia
iatrogenic neurologic disorders
immunotherapy
interferon
interferon beta 1-a
interferon beta 1-b
intracerebral hemorrhage
ketogenic diet
lamotrigine
lamotrigine, extended release
lawsuit
leukocytosis
leukopenia
levonorgestrel
liver function enzymes
lymphopenia
medical app
medical-legal aspects of neurology
medication withdrawal
meningitis
meningitis, bacterial
meningitis, hemophilus influenza
mephenytoin
misdiagnosis
mobile cardiac outpatient telemetry
mortality
multiple sclerosis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
neoplasm, primary of CNS
obstetric neurologic injuries
oral contraceptives
parietal lobe, lesion of
patient information and support
platelet inhibiting drugs
platelet inhibiting drugs, discontinuation
pleocytosis of cerebrospinal fluid
polypharmacy
practice guidelines
preexposure prophylaxis
pregnancy, anticonvulsants during
pregnancy, neurologic complications in
prenatal diagnosis by amniocentesis
prevention of neurologic disorders
prognosis
quality of life
review article
risk factors
safety
seizure
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, differential diagnosis of
seizure, driving with
seizure, drug-induced
seizure, employment with
seizure, etiology of
seizure, focal
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, pregnancy
seizure, prognosis in childhood
seizure, psychomotor-temporal lobe
seizure, psychosocial aspects of
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, monotherapy
seizure, treatment, adjunctive therapy
seizure, withdrawal
seizure, women
serum glutamic oxaloacetic transaminase
smartphone
sodium valproate
status epilepticus
steroid therapy, CNS treatment and complications with
syncope
syncope, driving with
telemetry, cardiac
thrombin inhibitor
thrombophlebitis
thrombophlebitis, prophylaxis
ticlopidine
transient ischemic attack
treatment of neurologic disorder
ultrasonography
vagus nerve stimulation
vitamin K
vitamin supplementation
weakness
work loss
Showing articles 0 to 40 of 40

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Stroke 48:1416-1419, Labovitz, D.L.,et al, 2017

Is Prophylactic Anticoagulation for Deep Venous Thrombosis Common Practice after Intracerebral Hemorrhage?
Stroke 46:369-375, Prabhakaran, S.,et al, 2015

Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015

Dietary Treatment in Adults with Refractory Epilepsy
Neurol 83:1978-1985, Klein, P.,et al, 2014

Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke
Stroke 44:528-530, Kamel, H.,et al, 2013

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

Preexposure Prophylaxis for HIV - Where Do We Go from Here?
NEJM 367:459-461,462, Cohen, M.S. & Baden, L.R., 2012

Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011

Failure to Take Antiepileptic Drugs as Prescribed
Arch Neurol 68:1318-1320, Modur, P.N., 2011

Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes: A Systematic Review
Arch Neurol 67:931-940, Neligan,A., et al, 2010

Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
Stroke 40:213-220, Kettani,F.-Z.,et al, 2009

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians
Stroke 39:227-230,7, Gattellari,M.,et al, 2008

Nonadherence to Antiepileptic Drugs and Increased Mortality: Findings from the RANsom Study
Neurol 71:1572-1578, Faught,E.,et al, 2008

American Academy of Neurology Position Statement on Physician Reporting of Medical Conditions That May Affect Driving Competence
Neurol 68: 1174-1177,1170, Bacon,D.,et al, 2007

Epilepsy in Pregnancy
BMJ 335:769-774, Tomson,T. &Hiilesmaa,V., 2007

Lamotrigine Extended-Release as Adjunctive Therapy for Partial Seizures
Neurol 69:1610-1618, Naritoku,D.K.,et al, 2007

Factors Associated With Poor Compliance of Patients with Epilepsy Driving Restrictions
Neurol 67:869-871, Polychronopoulos,P.,et al, 2006

Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients
BMJ 326:21, Maas,R.,et al, 2003

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002

Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001

Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Optimizing Long-Term Patient Compliance
Neurol 45(Suppl 1):S25-S28, Cramer,J.A., 1995

Double-Blind Crossover of Tegretol-XR and Tegretol in Patients with Epilepsy
Tegretol OROS Study Grp, Neurol 45:1703-17071995., , 1995

Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994

Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994

Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993

Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992

Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989

The Effects of Storage and Shaking on the Settling Properties of Phenytoin Suspension
Neurol 39:207-209, Sarkar,M.A.,et al, 1989

How Often is Medication Taken as Prescribed? A Novel Assessment Technique
JAMA 261:3273-3277, Cramer,J.A.,et al, 1989

Level Off
Neurol 1009-1010, Dodson,W.E., 1989

The Measurement of Anticonvulsant Agent Levels
Ann Int Med 100:854-858, Troupin,A.S., 1984

Status Epilepticus
Am J Med 69:657-665, Aminoff,M.J.,et al, 1980

Compliance in Anticonvulsant Drug Therapy
Epilepsia 16:203, Eisler,J.,et al, 1975

Checking Compliance of Epileptic Patients
NEJM 287:934, Livingston,S., 1972



Showing articles 0 to 40 of 40